Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.
Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Apter D, Jost M, Foidart JM, Creinin MD. Jensen JT, et al. Among authors: apter d. Contraception. 2022 Dec;116:37-43. doi: 10.1016/j.contraception.2022.07.009. Epub 2022 Jul 31. Contraception. 2022. PMID: 35921870 Free article. Clinical Trial.
Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia.
Gemzell-Danielsson K, Apter D, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Jost M, Creinin MD, Foidart JM. Gemzell-Danielsson K, et al. Among authors: apter d. BJOG. 2022 Jan;129(1):63-71. doi: 10.1111/1471-0528.16840. Epub 2021 Aug 9. BJOG. 2022. PMID: 34245666 Free PMC article. Clinical Trial.
Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature.
Palacios S, Regidor PA, Colli E, Skouby SO, Apter D, Roemer T, Egarter C, Nappi RE, Skřivánek A, Jakimiuk AJ, Weyers S, Ács N, Elia D, Gemzell Danielsson K, Bitzer J. Palacios S, et al. Among authors: apter d. Eur J Contracept Reprod Health Care. 2020 Jun;25(3):221-227. doi: 10.1080/13625187.2020.1743828. Epub 2020 Apr 21. Eur J Contracept Reprod Health Care. 2020. PMID: 32312141 Review.
Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials.
Archer DF, Merkatz RB, Bahamondes L, Westhoff CL, Darney P, Apter D, Jensen JT, Brache V, Nelson AL, Banks E, Bártfai G, Portman DJ, Plagianos M, Dart C, Kumar N, Creasy GW, Sitruk-Ware R, Blithe DL. Archer DF, et al. Among authors: apter d. Lancet Glob Health. 2019 Aug;7(8):e1054-e1064. doi: 10.1016/S2214-109X(19)30265-7. Epub 2019 Jun 20. Lancet Glob Health. 2019. PMID: 31231065 Free PMC article.
The risk of cervical atypia in oral contraceptive users.
Adhikari I, Eriksson T, Luostarinen T, Lehtinen M, Apter D. Adhikari I, et al. Among authors: apter d. Eur J Contracept Reprod Health Care. 2018 Feb;23(1):12-17. doi: 10.1080/13625187.2018.1431214. Epub 2018 Feb 7. Eur J Contracept Reprod Health Care. 2018. PMID: 29412045
156 results